DYBELENT Trademark

Trademark Overview

On Friday, April 27, 2007, a trademark application was filed for DYBELENT with the United States Patent and Trademark Office. The USPTO has given the DYBELENT trademark a serial number of 77167186. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, June 29, 2007. This trademark is owned by Glaxo Group Limited. The DYBELENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines
dybelent

General Information

Serial Number77167186
Word MarkDYBELENT
Filing DateFriday, April 27, 2007
Status601 - ABANDONED - EXPRESS
Status DateFriday, June 29, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 1, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN

Trademark Events

Event DateEvent Description
Friday, June 29, 2007ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Friday, June 29, 2007ABANDONMENT - EXPRESS MAILED
Thursday, June 28, 2007TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, May 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

dybelent treatment disorders diseases respiratory neurological gastrointestinal dysfunction ophthalmological hepatological hormonal